D.E. Shaw & Co
CSII

D.E. Shaw & Co’s Cardiovascular Systems, Inc. CSII Stock Holding History

D.E. Shaw & Co’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-206,279
Closed -$4.1M – 4813
2023
Q1 		$4.1M Sell
206,279
-183,214
-47% -$3.16M ﹤0.01% 2110
2022
Q4 		$5.3M Sell
389,493
-9,111
-2% -$127K 0.01% 2039
2022
Q3 		$5.53M Buy
398,604
+74,613
+23% +$1.11M 0.01% 1974
2022
Q2 		$4.65M Sell
323,991
-7,926
-2% -$138K 0.01% 2215
2022
Q1 		$7.5M Buy
331,917
+132,349
+66% +$2.57M 0.01% 1885
2021
Q4 		$3.75M Buy
199,568
+118,050
+145% +$3.15M ﹤0.01% 2710
2021
Q3 		$2.68M Buy
81,518
+43,939
+117% +$1.64M ﹤0.01% 2738
2021
Q2 		$1.6M Sell
37,579
-25,584
-41% -$1M ﹤0.01% 3156
2021
Q1 		$2.42M Sell
63,163
-13,361
-17% -$569K ﹤0.01% 2435
2020
Q4 		$3.35M Buy
76,524
+4,653
+6% +$175K ﹤0.01% 2183
2020
Q3 		$2.83M Buy
71,871
+37,814
+111% +$1.22M ﹤0.01% 2124
2020
Q2 		$1.07M Sell
34,057
-4,460
-12% -$167K ﹤0.01% 2880
2020
Q1 		$1.36M Sell
38,517
-29,426
-43% -$1.24M ﹤0.01% 2493
2019
Q4 		$3.3M Sell
67,943
-55,441
-45% -$2.52M ﹤0.01% 2070
2019
Q3 		$5.86M Sell
123,384
-92,426
-43% -$4.34M 0.01% 1526
2019
Q2 		$9.26M Sell
215,810
-177,803
-45% -$6.9M 0.01% 1175
2019
Q1 		$15.2M Sell
393,613
-442,980
-53% -$15M 0.02% 862
2018
Q4 		$23.8M Buy
836,593
+12,645
+2% +$402K 0.03% 629
2018
Q3 		$32.2M Buy
823,948
+109,608
+15% +$4.05M 0.04% 558
2018
Q2 		$23.1M Sell
714,340
-49,161
-6% -$1.35M 0.03% 647
2018
Q1 		$16.7M Sell
763,501
-183,421
-19% -$4.41M 0.02% 748
2017
Q4 		$22.4M Buy
946,922
+84,664
+10% +$2.13M 0.03% 633
2017
Q3 		$24.3M Sell
862,258
-31,758
-4% -$966K 0.04% 538
2017
Q2 		$28.8M Buy
894,016
+207,082
+30% +$6.31M 0.05% 460
2017
Q1 		$19.4M Sell
686,934
-149,416
-18% -$3.97M 0.03% 590
2016
Q4 		$20.2M Sell
836,350
-139,133
-14% -$3.41M 0.03% 616
2016
Q3 		$23.2M Buy
975,483
+159,558
+20% +$3.49M 0.04% 519
2016
Q2 		$15M Buy
815,925
+136,065
+20% +$2.13M 0.03% 660
2016
Q1 		$7.05M Buy
679,860
+44,508
+7% +$451K 0.01% 1064
2015
Q4 		$9.61M Buy
635,352
+38,682
+6% +$574K 0.01% 991
2015
Q3 		$9.45M Buy
596,670
+268,402
+82% +$6.76M 0.01% 992
2015
Q2 		$8.68M Buy
328,268
+98,629
+43% +$3.19M 0.01% 1102
2015
Q1 		$8.96M Buy
229,639
+89,755
+64% +$3.09M 0.01% 1030
2014
Q4 		$4.21M Buy
139,884
+75,929
+119% +$2.17M 0.01% 1698
2014
Q3 		$1.51M Buy
63,955
+26,399
+70% +$751K ﹤0.01% 2456
2014
Q2 		$1.17M Sell
37,556
-169,523
-82% -$4.89M ﹤0.01% 2789
2014
Q1 		$6.58M Buy
207,079
+83,920
+68% +$2.77M 0.01% 1363
2013
Q4 		$4.22M Buy
123,159
+63,679
+107% +$1.85M 0.01% 1838
2013
Q3 		$1.19M Sell
59,480
-42,718
-42% -$889K ﹤0.01% 2878
2013
Q2 		$2.17M Buy
+102,198
New +$1.99M ﹤0.01% 2041

Other funds holding CSII

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's CSII Position: Q2 2023 in Review

D.E. Shaw & Co sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 206,279 shares — an estimated $4.1M sold.

D.E. Shaw & Co first reported a position in CSII in Q2 2013 and held it in 40 quarters. The position peaked at $32.2M in Q3 2018. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • D.E. Shaw & Co reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 206,279 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $4.1M.
  • D.E. Shaw & Co first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 40 quarters.
  • D.E. Shaw & Co's Cardiovascular Systems, Inc. position peaked at $32.2M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.